1. Home
  2. SEPN vs WIW Comparison

SEPN vs WIW Comparison

Compare SEPN & WIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • WIW
  • Stock Information
  • Founded
  • SEPN 2022
  • WIW 2004
  • Country
  • SEPN United States
  • WIW United States
  • Employees
  • SEPN N/A
  • WIW N/A
  • Industry
  • SEPN
  • WIW Finance Companies
  • Sector
  • SEPN
  • WIW Finance
  • Exchange
  • SEPN NYSE
  • WIW Nasdaq
  • Market Cap
  • SEPN 631.0M
  • WIW 532.9M
  • IPO Year
  • SEPN 2024
  • WIW N/A
  • Fundamental
  • Price
  • SEPN $5.70
  • WIW $8.77
  • Analyst Decision
  • SEPN Buy
  • WIW
  • Analyst Count
  • SEPN 4
  • WIW 0
  • Target Price
  • SEPN $33.00
  • WIW N/A
  • AVG Volume (30 Days)
  • SEPN 420.0K
  • WIW 229.9K
  • Earning Date
  • SEPN 03-27-2025
  • WIW 01-01-0001
  • Dividend Yield
  • SEPN N/A
  • WIW 11.14%
  • EPS Growth
  • SEPN N/A
  • WIW N/A
  • EPS
  • SEPN N/A
  • WIW N/A
  • Revenue
  • SEPN $1,075,000.00
  • WIW N/A
  • Revenue This Year
  • SEPN N/A
  • WIW N/A
  • Revenue Next Year
  • SEPN N/A
  • WIW N/A
  • P/E Ratio
  • SEPN N/A
  • WIW N/A
  • Revenue Growth
  • SEPN 611.92
  • WIW N/A
  • 52 Week Low
  • SEPN $4.17
  • WIW $8.01
  • 52 Week High
  • SEPN $28.99
  • WIW $9.37
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • WIW 57.39
  • Support Level
  • SEPN N/A
  • WIW $8.63
  • Resistance Level
  • SEPN N/A
  • WIW $8.83
  • Average True Range (ATR)
  • SEPN 0.00
  • WIW 0.06
  • MACD
  • SEPN 0.00
  • WIW -0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • WIW 70.00

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About WIW Western Asset Inflation-Linked Opportunities & Income Fund

Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.

Share on Social Networks: